Cargando…
Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy
Hepatocyte growth factor and its receptor cMet activate biological pathways necessary for repair and regeneration following kidney injury. Here, we evaluated the clinical role of urinary cMet as a prognostic biomarker in diabetic nephropathy (DN). A total of 218 patients with DN were enrolled in thi...
Autores principales: | Kim, Yong Chul, An, Jung Nam, Kim, Jin Hyuk, Choi, Young-Wook, Oh, Sohee, Kwon, Sang Ho, Lee, Mi-Young, Lee, Junghun, Jeong, Jae-Gyun, Lim, Chun Soo, Kim, Yon Su, Yang, Seung Hee, Lee, Jung Pyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109090/ https://www.ncbi.nlm.nih.gov/pubmed/30143691 http://dx.doi.org/10.1038/s41598-018-31121-1 |
Ejemplares similares
-
Urinary cMet as a prognostic marker in immunoglobulin A nephropathy
por: An, Jung Nam, et al.
Publicado: (2020) -
Renoprotective effects of a novel cMet agonistic antibody on kidney fibrosis
por: Kim, Yong Chul, et al.
Publicado: (2019) -
cMet agonistic antibody attenuates apoptosis in ischaemia‐reperfusion–induced kidney injury
por: An, Jung Nam, et al.
Publicado: (2020) -
Hepatocyte growth factor and soluble cMet levels in plasma are prognostic biomarkers of mortality in patients with severe acute kidney injury
por: Li, Lilin, et al.
Publicado: (2021) -
Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma
por: Lohberger, Birgit, et al.
Publicado: (2021)